New lupus drug under Real-World watch: does it deliver?
NCT ID NCT05637112
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 26 times
Summary
This study follows about 550 people with lupus who are starting a new medication called anifrolumab. Researchers want to see how well the drug controls disease activity and improves quality of life in routine medical practice, not just in controlled trials. The goal is to give doctors and patients clearer information on what to expect from this treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Innsbruck, Tyrol, 6020, Austria
-
Research Site
Linz, Upper Austria, 4020, Austria
-
Research Site
Vienna, 1180, Austria
-
Research Site
Liège, Li Ge, 4000, Belgium
-
Research Site
Aalst, Oost-Vlaanderen, 9300, Belgium
-
Research Site
Bruges, West Flanders, 8000, Belgium
-
Research Site
Leuven, 3000, Belgium
-
Research Site
Calgary, Alberta, T2N 4N1, Canada
-
Research Site
Winnipeg, Manitoba, RR149, Canada
-
Research Site
Hamilton, Ontario, L8N 3Z5, Canada
-
Research Site
Orillia, Ontario, L3V 1T5, Canada
-
Research Site
Toronto, Ontario, M5T 2S9, Canada
-
Research Site
Rimouski, Quebec, G5L 5T1, Canada
-
Research Site
Sherbrooke, Quebec, J1G 2E8, Canada
-
Research Site
Ste-Foy, Quebec, G1V 4G2, Canada
-
Research Site
Nice, Alpes-Maritimes, 6000, France
-
Research Site
Clermont-Ferrand, Auvergne-Rh ne-Alpes, 63000, France
-
Research Site
Strasbourg, Bas-Rhin, 67098, France
-
Research Site
Finist Re, Brest Cedex, 29609, France
-
Research Site
Dijon, C te-d'Or, 21079, France
-
Research Site
Bordeaux, Gironde, 33076, France
-
Research Site
Grenoble, Is Re, 38043, France
-
Research Site
Saint-Denis, La R Union, 97405, France
-
Research Site
Nantes, Loire-Atlantique, 44093, France
-
Research Site
Bouches-du-Rh Ne, Lyon, 69003, France
-
Research Site
FORT de France Cedex, Martinique, 97261, France
-
Research Site
Lille, Nord, 59037, France
-
Research Site
Seine-Maritime, Rouen, 76230, France
-
Research Site
Paris, 14033, France
-
Research Site
Paris, 75013, France
-
Research Site
Paris, 75014, France
-
Research Site
Paris, 75020, France
-
Research Site
Paris, 75475, France
-
Research Site
Heidelberg, Baden-W Rttemberg, 69120, Germany
-
Research Site
Heidelberg, Baden-Wurttemberg, 69120, Germany
-
Research Site
Erlangen, Bavaria, 91054, Germany
-
Research Site
Bad Bramstedt, Free and Hanseatic City of Hamburg, 24576, Germany
-
Research Site
Schleswig-Holstein, L Beck, 23562, Germany
-
Research Site
Greifswald, Mecklenburg-Vorpommern, 17493, Germany
-
Research Site
Munich, Monachium, 81925, Germany
-
Research Site
Cologne, North Rhine-Westphalia, 51149, Germany
-
Research Site
D Sseldorf, North Rhine-Westphalia, 40225, Germany
-
Research Site
Herne, North Rhine-Westphalia, 44649, Germany
-
Research Site
Mainz A. Rhein, Rhineland-Palatinate, 55131, Germany
-
Research Site
Magdeburg, Saxony-Anhalt, 39104, Germany
-
Research Site
Greifwald, Vorpommern-Greifswald, 17489, Germany
-
Research Site
Berlin, 10117, Germany
-
Research Site
Kfar Saba, Central District, 4428164, Israel
-
Research Site
Tel Hashomer, Central District, 5211401, Israel
-
Research Site
Tiberias, Galilee, 15208, Israel
-
Research Site
Haifa, Haifa District, 3109601, Israel
-
Research Site
Haifa, Haifa District, 3436212, Israel
-
Research Site
Jerusalem, Jerusalem, 91120, Israel
-
Research Site
Afula, Northern District, 18101, Israel
-
Research Site
Ramat Gan, Tel Aviv, 52621, Israel
-
Research Site
Tel Aviv, Tel Aviv, 6423906, Israel
-
Research Site
Naples, Campania, 80131, Italy
-
Research Site
Cona, Emilia-Romagna, 44124, Italy
-
Research Site
Udine, Friuli Venezia Giulia, 33100, Italy
-
Research Site
Rome, Lazio, 149, Italy
-
Research Site
Brescia, Lombardy, 25100, Italy
-
Research Site
Milan, Lombardy, 20122, Italy
-
Research Site
Turin, Piedmont, 10126, Italy
-
Research Site
Cagliari, Sardinia, 9042, Italy
-
Research Site
Ancona, 60126, Italy
-
Research Site
Bari, 70124, Italy
-
Research Site
Florence, 50134, Italy
-
Research Site
Milan, 20122, Italy
-
Research Site
Milan, 20132, Italy
-
Research Site
Pisa, 56126, Italy
-
Research Site
Roma, 161, Italy
-
Research Site
Roma, 168, Italy
-
Research Site
Örebro, N Rke, 70185, Sweden
-
Research Site
Danderyd, Stockholm County, 18288, Sweden
-
Research Site
Stockholm, Uppland, 171 76, Sweden
-
Research Site
Dubai, Dubayy, 7272, United Arab Emirates
-
Research Site
Dubai, Dubayy, United Arab Emirates
-
Research Site
Sharjah city, Emirate of Sharjah, 72772, United Arab Emirates
-
Research Site
Abu Dhabi, United Arab Emirates
Conditions
Explore the condition pages connected to this study.